Alzheimer's disease 'more difficult to diagnose in men'

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |September 1, 2016
    PubMed

    Insights

    Diagnosing dementia in men may be challenging, potentially explaining higher reported rates in women. This study explores potential diagnostic difficulties and their impact on dementia prevalence data.

    Area of Science:

    • Neurology
    • Gerontology
    • Medical Diagnostics

    Background:

    • Dementia prevalence appears higher in women, but reasons are unclear.
    • Diagnostic challenges may influence observed sex differences in dementia rates.

    Purpose of the Study:

    • To investigate potential diagnostic difficulties in men with dementia.
    • To explore how diagnostic biases might contribute to sex-based prevalence disparities in dementia.

    Main Methods:

    • Review of existing literature on dementia diagnosis in men and women.
    • Analysis of diagnostic criteria and their application across sexes.
    • Exploration of potential sex-specific symptom presentation impacting diagnosis.

    Main Results:

    • Evidence suggests certain dementia symptoms may present differently in men, complicating diagnosis.
    • Diagnostic tools may not adequately account for sex-specific variations in cognitive decline.
    • Underdiagnosis in men could artificially inflate the apparent higher incidence in women.

    Conclusions:

    • Difficulties in diagnosing dementia in men may contribute to the observed higher prevalence in women.
    • Further research is needed to refine diagnostic approaches for dementia, considering sex-specific factors.

    Related Concept Videos

    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
    1.9K
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    1.1K
    Dementia01:30

    Dementia

    Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
    The progression of dementia is generally gradual....
    658